Aktienanleihen finden
Nähere Informationen zum Handelssegment EASY EUWAX finden Sie hier.
► Tipp: Abonnieren Sie unsere Newsletter, um immer auf dem Laufenden bei aktuellen Wertpapierentwicklungen zu bleiben.
Ihre Auswahl:
65 Ergebnisse
| DU4DT1 | Eli Lilly & Co./Aktienanleihe/5,33%/Call/DZ | - | - | 5,330 % | - | Eli Lilly & Co. | 1.075,470 | 04.06.2027 | 4,649130 | DZ Bank | ||
| HV4YYZ |  | Eli Lilly & Co./Aktienanleihe/8,6%/Call/UniCredit | - | - | 8,600 % | 0,221 % | Eli Lilly & Co. | 738,640 | 10.09.2026 | 1,353839 | Unicredit | |
| HV4Z47 | | Eli Lilly & Co./Aktienanleihe/7,6%/Call/UniCredit | - | - | 7,600 % | 3,183 % | Eli Lilly & Co. | 862,860 | 04.11.2026 | 1,158937 | Unicredit | |
| HVB91B | | Eli Lilly & Co./Aktienanleihe/8,95%/Call/UniCredit | - | - | 8,950 % | - | Eli Lilly & Co. | 702,592 | 30.03.2027 | 1,423301 | Unicredit | |
| HW7MYX | | Eli Lilly & Co./Aktienanleihe/8,34%/Call/UniCredit | - | - | 8,340 % | - | Eli Lilly & Co. | 590,912 | 08.09.2026 | 16,922994 | Unicredit | |
| HW7REG | | Eli Lilly & Co./Aktienanleihe/7,3%/Call/UniCredit | - | - | 7,300 % | - | Eli Lilly & Co. | 1.073,290 | 19.01.2029 | 0,931715 | Unicredit | |
| UN936H | | Eli Lilly & Co./Aktienanleihe/11,3%/Call/UniCredit | - | - | 11,300 % | - | Eli Lilly & Co. | 914,175 | 18.05.2027 | 1,093882 | Unicredit | |
| UN937T | | Eli Lilly & Co./Aktienanleihe/7,5%/Call/UniCredit | - | - | 7,500 % | 8,086 % | Eli Lilly & Co. | 906,400 | 16.06.2027 | 1,103266 | Unicredit | |
| UN957Y | | Eli Lilly & Co./Aktienanleihe/7,8%/Call/UniCredit | - | - | 7,800 % | 8,068 % | Eli Lilly & Co. | 943,288 | 21.07.2027 | 1,060122 | Unicredit | |
| VH40T0 | | Multi/Aktienanleihe/12,05%/Call/VONT | - | - | 12,050 % | 20,818 % | Novo-Nordisk AS | 306,000 | 30.11.2026 | 3,267970 | Vontobel | |
| VH5HFS | | Multi/Aktienanleihe/12,5%/Call/VONT | - | - | 12,500 % | - | Merck KGaA | 808,960 | 25.09.2026 | 8,853475 | Vontobel | |
| VH6UJZ | | Eli Lilly & Co./Aktienanleihe/6%/Call/VONT | - | - | 6,000 % | 2,892 % | Eli Lilly & Co. | 896,530 | 25.09.2026 | 1,115410 | Vontobel | |
| VH8TQ7 | | Eli Lilly & Co./Aktienanleihe/7,25%/Call/VONT | - | - | 7,250 % | 5,407 % | Eli Lilly & Co. | 1.070,160 | 25.09.2026 | 0,934440 | Vontobel | |
| VH9AK8 | | Multi/Aktienanleihe/13,25%/Call/VONT | - | - | 13,250 % | - | Novo-Nordisk AS | 25,270 | 25.09.2026 | 3,180156 | Vontobel | |
| VJ5FU1 | | Eli Lilly & Co./Aktienanleihe/10,5%/Call/VONT | - | - | 10,500 % | 11,484 % | Eli Lilly & Co. | 1.058,560 | 28.12.2026 | 0,944680 | Vontobel | |
| VJ6AKC | | Eli Lilly & Co./Aktienanleihe/18,25%/Call/VONT | - | - | 18,250 % | 20,220 % | Eli Lilly & Co. | 1.150,000 | 28.12.2026 | 0,869570 | Vontobel | |
| VJ6AKE | | Eli Lilly & Co./Aktienanleihe/23%/Call/VONT | - | - | 23,000 % | 14,357 % | Eli Lilly & Co. | 1.250,000 | 28.12.2026 | 0,800000 | Vontobel | |
| VJ6AKF | | Eli Lilly & Co./Aktienanleihe/20,5%/Call/VONT | - | - | 20,500 % | 18,730 % | Eli Lilly & Co. | 1.200,000 | 28.12.2026 | 0,833330 | Vontobel | |
| VJ6AKG | | Eli Lilly & Co./Aktienanleihe/16%/Call/VONT | - | - | 16,000 % | 17,169 % | Eli Lilly & Co. | 1.100,000 | 28.12.2026 | 0,909090 | Vontobel | |
| VJ6AKH | | Eli Lilly & Co./Aktienanleihe/11,5%/Call/VONT | - | - | 11,500 % | 11,384 % | Eli Lilly & Co. | 1.000,000 | 28.12.2026 | 1,000000 | Vontobel | |
| VJ6AKJ | | Eli Lilly & Co./Aktienanleihe/13,75%/Call/VONT | - | - | 13,750 % | 13,770 % | Eli Lilly & Co. | 1.050,000 | 28.12.2026 | 0,952380 | Vontobel | |
| VJ6AKK | | Eli Lilly & Co./Aktienanleihe/7,75%/Call/VONT | - | - | 7,750 % | 7,103 % | Eli Lilly & Co. | 900,000 | 28.12.2026 | 1,111110 | Vontobel | |
| VJ6AKL | | Eli Lilly & Co./Aktienanleihe/9,5%/Call/VONT | - | - | 9,500 % | 8,980 % | Eli Lilly & Co. | 950,000 | 28.12.2026 | 1,052630 | Vontobel | |
| VJ6AKM | | Eli Lilly & Co./Aktienanleihe/16%/Call/VONT | - | - | 16,000 % | 10,666 % | Eli Lilly & Co. | 1.250,000 | 24.06.2027 | 0,800000 | Vontobel | |
| VJ6AKN | | Eli Lilly & Co./Aktienanleihe/6,25%/Call/VONT | - | - | 6,250 % | 5,665 % | Eli Lilly & Co. | 850,000 | 28.12.2026 | 1,176470 | Vontobel | |
| VJ6AKP | | Eli Lilly & Co./Aktienanleihe/6,75%/Call/VONT | - | - | 6,750 % | 7,585 % | Eli Lilly & Co. | 900,000 | 24.06.2027 | 1,111110 | Vontobel | |
| VJ6AKQ | | Eli Lilly & Co./Aktienanleihe/13,25%/Call/VONT | - | - | 13,250 % | 14,060 % | Eli Lilly & Co. | 1.150,000 | 24.06.2027 | 0,869570 | Vontobel | |
| VJ6AKR | | Eli Lilly & Co./Aktienanleihe/10,5%/Call/VONT | - | - | 10,500 % | 11,231 % | Eli Lilly & Co. | 1.050,000 | 24.06.2027 | 0,952380 | Vontobel | |
| VJ6AKS | | Eli Lilly & Co./Aktienanleihe/11,75%/Call/VONT | - | - | 11,750 % | 12,608 % | Eli Lilly & Co. | 1.100,000 | 24.06.2027 | 0,909090 | Vontobel | |
| VJ6AKT | | Eli Lilly & Co./Aktienanleihe/14,5%/Call/VONT | - | - | 14,500 % | 13,188 % | Eli Lilly & Co. | 1.200,000 | 24.06.2027 | 0,833330 | Vontobel | |
| VJ6AKU | | Eli Lilly & Co./Aktienanleihe/8%/Call/VONT | - | - | 8,000 % | 8,762 % | Eli Lilly & Co. | 950,000 | 24.06.2027 | 1,052630 | Vontobel | |
| VJ6AKV | | Eli Lilly & Co./Aktienanleihe/5,5%/Call/VONT | - | - | 5,500 % | 6,545 % | Eli Lilly & Co. | 850,000 | 24.06.2027 | 1,176470 | Vontobel | |
| VJ6AKW | | Eli Lilly & Co./Aktienanleihe/9,25%/Call/VONT | - | - | 9,250 % | 9,938 % | Eli Lilly & Co. | 1.000,000 | 24.06.2027 | 1,000000 | Vontobel | |
| VJ8PCH | | Eli Lilly & Co./Aktienanleihe/14,5%/Call/VONT | - | - | 14,500 % | 12,477 % | Eli Lilly & Co. | 1.100,000 | 24.06.2027 | 0,909090 | Vontobel | |
| VJ8PCJ | | Eli Lilly & Co./Aktienanleihe/23,25%/Call/VONT | - | - | 23,250 % | 19,862 % | Eli Lilly & Co. | 1.150,000 | 28.12.2026 | 0,869570 | Vontobel | |
| VJ8PCM | | Eli Lilly & Co./Aktienanleihe/16%/Call/VONT | - | - | 16,000 % | 13,748 % | Eli Lilly & Co. | 1.150,000 | 24.06.2027 | 0,869570 | Vontobel | |
| VJ8PCN | | Eli Lilly & Co./Aktienanleihe/13%/Call/VONT | - | - | 13,000 % | 11,099 % | Eli Lilly & Co. | 1.050,000 | 24.06.2027 | 0,952380 | Vontobel | |
| VJ8T31 | | Eli Lilly & Co./Aktienanleihe/19%/Call/VONT | - | - | 19,000 % | 13,606 % | Eli Lilly & Co. | 1.050,000 | 28.12.2026 | 0,952380 | Vontobel | |
| VJ8T32 | | Eli Lilly & Co./Aktienanleihe/21,75%/Call/VONT | - | - | 21,750 % | 16,294 % | Eli Lilly & Co. | 1.100,000 | 28.12.2026 | 0,909090 | Vontobel | |
| VJ8T33 | | Eli Lilly & Co./Aktienanleihe/12,25%/Call/VONT | - | - | 12,250 % | 9,608 % | Eli Lilly & Co. | 1.000,000 | 24.06.2027 | 1,000000 | Vontobel | |
| VJ8T34 | | Eli Lilly & Co./Aktienanleihe/10,75%/Call/VONT | - | - | 10,750 % | 8,540 % | Eli Lilly & Co. | 950,000 | 24.06.2027 | 1,052630 | Vontobel | |
| VJ8T35 | | Eli Lilly & Co./Aktienanleihe/8%/Call/VONT | - | - | 8,000 % | 6,412 % | Eli Lilly & Co. | 850,000 | 24.06.2027 | 1,176470 | Vontobel | |
| VJ8T37 | | Eli Lilly & Co./Aktienanleihe/9,25%/Call/VONT | - | - | 9,250 % | 7,388 % | Eli Lilly & Co. | 900,000 | 24.06.2027 | 1,111110 | Vontobel | |
| VK9W3F | | Eli Lilly & Co./Aktienanleihe/5,8%/Call/VONT | - | - | 5,800 % | 0,270 % | Eli Lilly & Co. | 596,050 | 24.08.2026 | 1,677710 | Vontobel | |
| VY0CCG | | Eli Lilly & Co./Aktienanleihe/12%/Call/VONT | - | - | 12,000 % | 7,173 % | Eli Lilly & Co. | 929,550 | 23.04.2027 | 1,075790 | Vontobel | |
| VY0K39 | | Eli Lilly & Co./Aktienanleihe/9,25%/Call/VONT | - | - | 9,250 % | 5,404 % | Eli Lilly & Co. | 800,000 | 24.06.2027 | 1,250000 | Vontobel | |
| VY0K4E | | Eli Lilly & Co./Aktienanleihe/11,25%/Call/VONT | - | - | 11,250 % | 4,482 % | Eli Lilly & Co. | 800,000 | 28.12.2026 | 1,250000 | Vontobel | |
| VY0K4G | | Eli Lilly & Co./Aktienanleihe/15,75%/Call/VONT | - | - | 15,750 % | 9,353 % | Eli Lilly & Co. | 1.000,000 | 24.06.2027 | 1,000000 | Vontobel | |
| VY0LBA | | Eli Lilly & Co./Aktienanleihe/16,5%/Call/VONT | - | - | 16,500 % | 6,711 % | Eli Lilly & Co. | 900,000 | 28.12.2026 | 1,111110 | Vontobel | |
| VY0LBE | | Eli Lilly & Co./Aktienanleihe/22,5%/Call/VONT | - | - | 22,500 % | 10,490 % | Eli Lilly & Co. | 1.000,000 | 28.12.2026 | 1,000000 | Vontobel |